Literature DB >> 12888114

Reducing GABA receptors.

David R Burt1.   

Abstract

A number of important drugs act on GABA(A) receptors, pentameric GABA-gated chloride channels assembled from among 19 known subunits. In trying to discover the roles in the brain of the subunits and their combinations, with the goal of developing more selective drugs, one tool has been to reduce expression of the subunits and examine the functional consequences. After briefly examining the properties of GABA(A) receptors, this review surveys the means available for receptor subunit reduction, and some of the observations to which their application has led. The methods discussed include radiation-induced deletion, gene knockout, knock-in mutations, antisense, ribozymes, RNA interference, dominant negative constructs, and transcriptional regulation, e.g., via decoy oligonucleotides.

Mesh:

Substances:

Year:  2003        PMID: 12888114     DOI: 10.1016/s0024-3205(03)00505-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  5-tert-Butyl-2-(4'-[18F]fluoropropynylphenyl)-1,3-dithiane oxides: potential new GABA A receptor radioligands.

Authors:  Xuehe Li; Yong-Woon Jung; Scott E Snyder; Joseph Blair; Philip S Sherman; Timothy Desmond; Kirk A Frey; Michael R Kilbourn
Journal:  Nucl Med Biol       Date:  2007-11-26       Impact factor: 2.408

2.  1,5-benzodiazepines, a novel class of hepatitis C virus polymerase nonnucleoside inhibitors.

Authors:  Origène Nyanguile; Frederik Pauwels; Walter Van den Broeck; Carlo W Boutton; Ludo Quirynen; Tania Ivens; Liesbet van der Helm; Geneviève Vandercruyssen; Wendy Mostmans; Frédéric Delouvroy; Pascale Dehertogh; Maxwell D Cummings; Jean-Francois Bonfanti; Kenneth A Simmen; Pierre Raboisson
Journal:  Antimicrob Agents Chemother       Date:  2008-10-13       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.